NCT02932176 Machine Learning for Handheld Vascular Studies
| NCT ID | NCT02932176 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Atherosclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2016-09-07 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2016-09-07 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The use of handheld arterial 'stethoscopes' (continuous wave Doppler devices) are ubiquitous in clinical practice. However, most users have received no formal training in their use or the interpretation of the returned data. This leads to delays in diagnosis and errors in diagnosis. The investigators intend to create a novel machine-learning algorithm to assist clinicians in the use of this data. This study will allow the investigators to collect sound files from the use of the devices and compare the algorithms output to established, existing vascular testing. There will be no invasive procedures, and use of these stethoscopes is part of routine clinical care. If successful, this data and algorithm will be later deployed via smartphone app for point of case testing in a separate study
Eligibility Criteria
Inclusion Criteria: * A clinically driven request for non-invasive vascular testing must be present Exclusion Criteria: * None (other than patient declines to participate)
Contact & Investigator
Leila Mureebe, MD
✉ leila.mureebe@duke.eduFrequently Asked Questions
Who can join the NCT02932176 clinical trial?
This trial is open to participants of all sexes, studying Atherosclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02932176 currently recruiting?
Yes, NCT02932176 is actively recruiting participants. Contact the research team at leila.mureebe@duke.edu for enrollment information.
Where is the NCT02932176 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT02932176 clinical trial?
NCT02932176 is sponsored by Duke University. The trial plans to enroll 180 participants.